IPP Bureau
Karkinos Healthcare launched ‘Advanced Center for Cancer Diagnostics and Research’
By IPP Bureau - June 12, 2022
India’s first oncology laboratory for comprehensive Cancer Diagnostic services
Quizartinib Plus chemotherapy significantly improved overall survival compared to chemo
By IPP Bureau - June 12, 2022
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
Alembic receives USFDA tentative approval for Dasatinib tablets
By IPP Bureau - June 12, 2022
Dasatinib Tablet is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive
Strides receives USFDA approval for Ibuprofen OTC oral suspension
By IPP Bureau - June 12, 2022
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Amytrx Therapeutic's AMTX-100 CF3 moves to phase II clinical trial for atopic dermatitis
By IPP Bureau - June 12, 2022
Amarex Clinical Research guides its client to phase II of FDA trials
Isotopia and CPDC deliver first doses of n.c.a. Lu-177 to North American customers
By IPP Bureau - June 12, 2022
The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America
Cantourage and Clever leaves intensify partnership for distribution of medical cannabis in Germany
By IPP Bureau - June 12, 2022
Cantourage introduces second Clever Leaves medical cannabis product to the German market
China NMPA approves Tislelizumab for metastatic nasopharyngeal cancer
By IPP Bureau - June 12, 2022
Tislelizumab is now approved in nine indications in China
Modi Inaugurates hospital complex and CoE in South Gujarat
By IPP Bureau - June 11, 2022
Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools
Eppendorf India inaugurates pipette laboratory and service hub in Chennai
By IPP Bureau - June 11, 2022
SPLASH also houses the tools’ calibration for epMotion, Eppendorf automated liquid handling workstations.
TaCa Healthcare expands its operations to Telangana and Andhra Pradesh
By IPP Bureau - June 11, 2022
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
By IPP Bureau - June 11, 2022
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Sanyou Biopharmaceuticals launches Super-Trillion Antibody Libraries
By IPP Bureau - June 11, 2022
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
AIkido Pharma appoints Soo Yu as Director
By IPP Bureau - June 11, 2022
New Director supports NASDAQ rule on diversity
Illumina appoints Joydeep Goswami as Interim CFO
By IPP Bureau - June 11, 2022
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
